Charles River Laboratories International (CRL) Competitors $166.89 -2.75 (-1.62%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$166.90 +0.01 (+0.01%) As of 08/1/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. ICLR, TECH, IQV, A, MTD, WAT, ILMN, BIO, BRKR, and PACBShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Icon (ICLR), Bio-Techne (TECH), IQVIA (IQV), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Bruker (BRKR), and Pacific Biosciences of California (PACB). Charles River Laboratories International vs. Its Competitors Icon Bio-Techne IQVIA Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Bruker Pacific Biosciences of California Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings. Which has higher earnings and valuation, ICLR or CRL? Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.62$791.47M$9.7217.12Charles River Laboratories International$4.05B2.02$22.20M-$0.65-256.75 Which has more risk & volatility, ICLR or CRL? Icon has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. Is ICLR or CRL more profitable? Icon has a net margin of 9.82% compared to Charles River Laboratories International's net margin of -0.66%. Charles River Laboratories International's return on equity of 15.19% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.82% 10.95% 6.23% Charles River Laboratories International -0.66%15.19%6.93% Do analysts prefer ICLR or CRL? Icon currently has a consensus target price of $219.54, indicating a potential upside of 31.90%. Charles River Laboratories International has a consensus target price of $174.54, indicating a potential upside of 4.58%. Given Icon's stronger consensus rating and higher probable upside, equities research analysts plainly believe Icon is more favorable than Charles River Laboratories International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 2.81Charles River Laboratories International 1 Sell rating(s) 10 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.25 Does the media favor ICLR or CRL? In the previous week, Icon had 2 more articles in the media than Charles River Laboratories International. MarketBeat recorded 14 mentions for Icon and 12 mentions for Charles River Laboratories International. Charles River Laboratories International's average media sentiment score of 1.44 beat Icon's score of 0.74 indicating that Charles River Laboratories International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 6 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charles River Laboratories International 11 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in ICLR or CRL? 95.6% of Icon shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 44.0% of Icon shares are owned by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryIcon beats Charles River Laboratories International on 11 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$8.33B$7.18B$5.49B$20.65BDividend YieldN/A2.90%4.73%3.67%P/E Ratio-256.7564.1328.7829.03Price / Sales2.0233.83372.2066.13Price / Cash7.8225.7735.4522.84Price / Book2.468.618.274.43Net Income$22.20M$239.96M$3.25B$994.22M7 Day Performance-5.63%-5.48%-3.70%-3.39%1 Month Performance5.96%-3.73%4.34%-2.09%1 Year Performance-28.55%18.27%25.90%10.09% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.3044 of 5 stars$166.89-1.6%$174.54+4.6%-31.3%$8.33B$4.05B-256.7520,100Positive NewsUpcoming EarningsICLRIcon4.5302 of 5 stars$189.66+1.4%$219.54+15.8%-49.1%$15.32B$8.28B19.5141,900TECHBio-Techne4.8672 of 5 stars$58.55-0.4%$69.58+18.8%-33.3%$9.18B$1.21B71.403,100News CoveragePositive NewsUpcoming EarningsIQVIQVIA4.8547 of 5 stars$197.73-0.7%$228.62+15.6%-26.5%$33.61B$15.41B28.6288,000Positive NewsAAgilent Technologies4.7728 of 5 stars$119.54-0.5%$139.77+16.9%-20.5%$33.96B$6.51B29.5217,900News CoveragePositive NewsMTDMettler-Toledo International3.8592 of 5 stars$1,259.15-0.4%$1,298.50+3.1%-20.9%$26.17B$3.87B31.4017,300Trending NewsEarnings ReportWATWaters4.7425 of 5 stars$302.51-0.1%$381.94+26.3%-17.5%$18.00B$2.96B27.457,600Trending NewsUpcoming EarningsShort Interest ↑ILMNIllumina4.9329 of 5 stars$109.88+0.5%$125.89+14.6%-22.6%$17.30B$4.34B-18.109,030Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownBIOBio-Rad Laboratories4.6659 of 5 stars$253.24-4.1%$324.25+28.0%-16.6%$6.89B$2.57B-3.327,700Trending NewsEarnings ReportAnalyst ForecastGap UpBRKRBruker4.9572 of 5 stars$43.93+4.7%$52.89+20.4%-44.4%$6.66B$3.45B84.4811,396Upcoming EarningsPACBPacific Biosciences of California2.528 of 5 stars$1.64+6.5%$2.06+25.7%-30.7%$492.13M$154.01M-0.59730Upcoming Earnings Related Companies and Tools Related Companies Icon Alternatives Bio-Techne Alternatives IQVIA Alternatives Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
